SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Yamate T, Mocharla H, Taguchi Y, Igietseme JU, Manolagas SC, Abe E 1997 Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: Demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy. Endocrinology 138:30473055.
  • 2
    Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R 1996 Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 60:540545.
  • 3
    Atkins K, Berry JE, Zhang WZ, Harris JF, Chambers AF, Simpson RU, Somerman MJ 1998 Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells. J Cell Physiol 175:229237.
  • 4
    Nakamura H, Kenmotsu S, Sakai H, Ozawa H 1995 Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tissue Res 280:225233.
  • 5
    Merry K, Dodds R, Littlewood A, Gowen M 1993 Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. J Cell Sci 104:10131020.
  • 6
    Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT 1998 Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:11011111.
  • 7
    Yoshitake H, Rittling SR, Denhardt DT, Noda M 1999 Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:81566810.
  • 8
    Ihara H, Denhardt DT, Furuya K, Yamashita T, Muguruma Y, Tsuji K, Hruska KA, Higashio K, Enomoto S, Nifuji A, Rittling SR, Noda M 2001 Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. J Biol Chem 276:1306513071.
  • 9
    Denhardt DT, Guo X 1993 Osteopontin: A protein with diverse functions. FASEB J 7:14751482.
  • 10
    Butler WT, Ridall A, McKee MD 1996 Osteopontin. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, USA, pp. 167181.
  • 11
    Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M 1998 Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353358.
  • 12
    Sodek J, Ganss B, McKee MD 2000 Osteopontin. Crit Rev Oral Biol Med 11:279303.
  • 13
    Rittling SR, Denhardt DT 1999 Osteopontin function in pathology: Lessons from osteopontin-deficient mice. Exp Nephrol 7:103113.
  • 14
    Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS 2001 Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling and cell survival. J Clin Invest 107:10551062.
  • 15
    Weber GF, Ashkar S, Glimcher MJ, Cantor H 1996 Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509512.
  • 16
    Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H 2000 Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287:860864.
  • 17
    Kubota T, Zhang Q, Wrana JL, Ber R, Aubin JE, Butler WT, Sodek J 1989 Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: Regulation by TGF-beta. Biochem Biophys Res Commun 162:14531459.
  • 18
    Singh K, DeVouge MW, Mukherjee BB 1990 Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J Biol Chem 265:1869618701.
  • 19
    Sodek J, Chen J, Nagata T, Kasugai S, Todescan R, Li IW, Kim RH 1995 Regulation of osteopontin expression in osteoblasts. Ann NY Acad Sci 760:223241.
  • 20
    Goldberg HA, Hunter GK 1995 The inhibitory activity of osteopontin on hydroxyapatite formation in vitro. Ann NY Acad Sci 760:305308.
  • 21
    Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G 1994 Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269:1485314856.
  • 22
    Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B 1990 CD44 is the principal cell surface receptor for hyaluronate. Cell 6:13031313.
  • 23
    Miyake K, Underhill CB, Lesley J, Kincade PW 1990 Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:6975.
  • 24
    Tolg C, Hofmann M, Herrlich P, Ponta H 1993 Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:12251229.
  • 25
    Naor D, Sionov RV, Ish-Shalom D 1997 CD44: Structure, function, and association with the malignant process. Adv Cancer Res 71:241319.
  • 26
    Tsukita S, Yonemura S, Tsukita S 1997 ERM proteins: Head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem Sci 22:5358.
  • 27
    Yonemura S, Tsukita S, Tsukita S 1999 Direct involvement of ezrin/radixin/moesin (ERM)-binding membrane proteins in the organization of microvilli in collaboration with activated ERM proteins. J Cell Biol 145:14971509.
  • 28
    Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T 1999 CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 59:219226.
  • 29
    Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CAG, Sodek J 2000 Intracellular OPN is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 184:118130.
  • 30
    Ly IA, Mishell RI 1974 Separation of mouse spleen cells by passage through column of Sephadex G-10. J Immunol Methods 5:239247.
  • 31
    Zhang Q, Domenicucci C, Goldberg HA, Wrana JL, J Sodek 1990 Characterization of fetal porcine bone sialoproteins: Secreted phosphoprotein 1 (SPP1, osteopontin), bone sialoprotein, and a 23 kDa glycoprotein. Demonstration that the 23 kDa glycoprotein is derived from the carboxy-terminus of SPP1. J Biol Chem 265:75837589.
  • 32
    Nakamura I, Tanaka H, Rodan GA, Duong LT 1998 Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells. Endocrinology 139:51825193.
  • 33
    Duong LT, Lakkakorpi P, Nakamura I, Rodan GA 2000 Integrins and signaling in osteoclast function. Matrix Biol 19:97105.
  • 34
    Duong LT, Rodan GA 1998 Integrin-mediated signaling in the regulation of osteoclast adhesion and activation. Front Biosci 3:D757D768.
  • 35
    Ganss B, Kim RH, Sodek J 1999 Bone sialoprotein. Crit Rev Oral Biol Med 10:7998.
  • 36
    Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y 2001 Tumor necrosis factor-alpha (TNFα) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 276:563568.
  • 37
    Faccio R, Grano M, Colucci S, Zallone AZ, Quaranta V, Pelletier AJ 1998 Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin. Biochem Biophys Res Commun 249:522555.
  • 38
    Zhu J, Suzuki K, Zohar R Suzuki S. Rittling SR, Denhardt DT, Goldberg HA, McCulloch CAG, Sodek J 2000 Functional significance of intracellular osteopontin associated with the CD44 receptor complex. J Bone Miner Res 15:S345.
  • 39
    Nakamura H, Ozawa H 1996 Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae. J Bone Miner Res 11:17151722.
  • 40
    Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF 1997 Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res 12:20142023.
  • 41
    Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T, Wakeham A, Shahinian A, Catzavelos C, Rak J, Furlonger C, Zakarian A, Simard JJ, Ohashi PS, Paige CJ, Gutierrez-Ramos JC, Mak TW 1997 CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90:22172233.
  • 42
    Noda M, Rittling SR, Mugurama Y, Asou Y, Yoshitake H, Tsuji K, Denhardt D 1998 Osteopontin-deficient mice (OD-) cells exhibit enhanced actin fibre formation and spreading while OD-osteoclasts are less efficient in removing hydroxyapatite coated on glass and in recruitment to ectopically implanted bone matrix. J Bone Miner Res 23:S220.
  • 43
    Yoshitake H, Rittling SR, Tsuji K, Yamashita T, Wong B, Choi D, Denhardt D, Noda M 1998 Osteopontin-deficient mice reveal increase in osteoclast number, enhanced TRANCE/RANKL/ODF expression in bone but are resistant to bone resorption that follows bone formation after bone marrow ablation. J Bone Miner Res 23:S200.
  • 44
    Giachelli CM, Steitz S 2000 Osteopontin: A versatile regulator of inflammation and biomineralization. Matrix Biol 19:615622.
  • 45
    Tani-Ishii N, Tsunoda A, Umemoto T 1997 Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro. J Periodontal Res 32:480486.
  • 46
    Legg JW, Isacke CM 1998 Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol 8:705708.
  • 47
    Nakamura I, Pilkington MF, Lakkakorpi PT, Lipfert L, Sims SM, Dixon SJ, Rodan GA, Duong LT 1999 Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone. J Cell Sci 112:39853993.
  • 48
    McHugh KP, Hodivala-Dilke K, Zheng M-H, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL 2000 Mice lacking β3 integrins are osteosclerotic due to dysfunctional osteoclasts. J Clin Invest 104:433440.
  • 49
    Kania JR, Kehat-Stadler T, Kupfer SR 1997 CD44 antibodies inhibit osteoclast formation. J Bone Miner Res 12:11551164.
  • 50
    Sodek J, Zhu B, Huynh M-H, Brown TJ, Ringuette M 2002 Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect Tissue Res (in press).
  • 51
    Katayama Y, House CM, Udagawa N, Kazama JJ, McFarland RJ, Martin TJ, Findlay DM 1998 Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts. J Cell Physiol 176:179187.
  • 52
    Harada N, Mizoi T, Kinouchi M, Hoshi K, Ishii S, Shiiba K, Sasaki I, Matsuno S 2001 Introduction of antisense CD44S cDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer 91:6775.
  • 53
    Uemura T, Liu YK, Kuboki Y 2000 mRNA expression of MT1-MMP, MMP-9, cathepsin K, and TRAP in highly enriched osteoclasts cultured on several matrix proteins and ivory surfaces. Biosci Biotechnol Biochem 64:17711773.
  • 54
    Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA 2000 Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol 148:665678.
  • 55
    Flanagan AM, Sarma U, Steward CG, Vellodi A, Horton MA 2000 Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: A new approach to investigating pathogenesis. J Bone Miner Res 15:352360.